E3	Condition:T3 Name:T78 Acuteness:T2
E5	Condition:T5 Name:T79
E6	Condition:T6 Name:T80 Duration:E7
E7	Eq-Comparison:T7 Operator:T81 Value:T82 Temporal-Unit:T83
E9	Eq-Comparison:T9 Operator:T84 Operator:T85 Value:T86 Per:T88
E11	Condition:T11 Name:T90
E12	Observation:T12 Name:T91 Numeric-Filter:E13
E13	Eq-Comparison:T13 Operator:T92 Value:T93 Unit:T94 Per:T95
E15	Observation:T15 Name:T96 Numeric-Filter:E16
E16	Eq-Comparison:T16 Operator:T97 Value:T98
E18	Condition:T18 Name:T100
E19	Procedure:T19 Name:T101
E20	Eq-Comparison:T20 Value:T102 Operator:T103
E21	Observation:T21 Name:T104 Minimum-Count:E20 Numeric-Filter:E22
E22	Eq-Comparison:T22 Value:T105 Operator:T106 Value:T107 Unit:T108
E23	Modifier:T23 Modifies:T104
E25	Observation:T25 Name:T110 Polarity:T109 Numeric-Filter:E26
E26	Eq-Comparison:T26 Operator:T111 Value:T112 Unit:T113
E28	Condition:T28 Name:T115
E29	Observation:T29 Name:T116 Minimum-Count:E78 Duration:E30 Numeric-Filter:E79
E30	Eq-Comparison:T30 Operator:T117 Value:T118 Temporal-Unit:T119
E32	Condition:T32 Name:T125
E34	Other:T34 Is-Other:E35
E35	Condition:T35 Name:T126
E37	Condition:T37 Name:T127
E39	Observation:T39 Name:T130 Polarity:T129 Numeric-Filter:E40
E40	Eq-Comparison:T40 Operator:T131 Value:T132 Unit:T133 Per:T134
E42	Condition:T42 Name:T136
E43	Observation:T43 Name:T138 Numeric-Filter:E44 Numeric-Filter:E46
E44	Eq-Comparison:T44 Operator:T139 Value:T140 Unit:T141 Per:T142
E46	Eq-Comparison:T46 Operator:T143 Value:T144 Unit:T145 Per:T146
E48	Assertion:T48 Asserted:E52
E49	Modifier:T49 Modifies:T148
E51	Modifier:T51 Modifies:T148
E52	Condition:T52 Name:T148
E55	Condition:T55 Name:T151
E56	Eq-Comparison:T56 Temporal-Period:T137
E57	Drug:T57 Temporality:E56
E58	Condition:T58 Name:T154 Stability:T153
E59	Drug:T59 Name:T155
E60	Drug:T60 Name:T156
E62	Other:T62 Is-Other:E64
E63	Drug:T63 
E64	Condition:T64 Name:T157
E66	Condition:T66 
E67	Contraindication:T67 Contraindicates:E68
E68	Drug:T68 Name:T159
E70	Eq-Comparison:T70 Temporal-Period:T160
E71	Allergy:T71 Temporality:E70 Name:E72 Name2:E74 Name3:E76
E72	Drug:T72 
E74	Drug:T74 Name:T161
E76	Drug:T76 Name:T162
E77	Observation:T163 Name:T87 Numeric-Filter:E9
E78	Eq-Comparison:T164 Value:T165
E79	Eq-Comparison:T166 Operator:T120 Value:T121 Unit:T122 Per:T123
E36	Modifier:T36 Modifies:T136
E53	Modifier:T53 Modifies:T148
E80	Assertion:T149 Asserted:T153
E81	Modifier:T167 Modifies:T157
T2	Acuteness 36 43	chronic
T3	Condition 44 55	anovulation
T5	Condition 59 73	oligomenorrhea
T6	Condition 85 119	spontaneous intermenstrual periods
T7	Eq-Comparison 123 155	greater than or equal to 45 days
T9	Eq-Comparison 170 193	less than or equal to 8
T11	Condition 227 243	Hyperandrogenism
T12	Observation 257 275	total testosterone
T13	Eq-Comparison 276 297	greater than 50 ng/dL
T15	Observation 303 322	free androgen index
T16	Eq-Comparison 323 338	greater than 10
T18	Condition 356 374	Polycystic Ovaries
T19	Procedure 378 388	Ultrasound
T20	Eq-Comparison 400 417	either 12 or more
T21	Observation 418 437	follicles measuring
T22	Eq-Comparison 438 444	2-9 mm
T23	Modifier 448 456	diameter
T25	Observation 470 484	ovarian volume
T26	Eq-Comparison 485 503	greater than 10 cm
T28	Condition 541 559	Hyperprolactinemia
T29	Observation 573 589	prolactin levels
T30	Eq-Comparison 590 607	at least one week
T32	Condition 659 684	21-hydroxylase deficiency
T34	Other 688 693	other
T35	Condition 694 711	enzyme deficiency
T37	Condition 727 757	congenital adrenal hyperplasia
T39	Observation 784 794	FSH levels
T40	Eq-Comparison 795 818	greater than 10 mIU/mL.
T42	Condition 847 862	thyroid disease
T43	Observation 912 915	TSH
T44	Eq-Comparison 916 937	less than 0.45 mIU/mL
T46	Eq-Comparison 941 964	greater than 4.5 MIU/mL
T48	Assertion 985 994	suspected
T49	Modifier 995 1002	adrenal
T51	Modifier 1006 1013	ovarian
T52	Condition 1014 1019	tumor
T55	Condition 1056 1074	Cushing's syndrome
T56	Eq-Comparison 1086 1088	on
T57	Drug 1101 1112	medications
T58	Condition 1126 1142	ovarian function
T59	Drug 1153 1162	metformin
T60	Drug 1164 1187	hormonal contraceptives
T62	Other 1191 1196	other
T63	Drug 1197 1208	medications
T64	Condition 1220 1228	diabetes
T66	Condition 1245 1263	medical conditions
T67	Contraindication 1273 1290	contraindications
T68	Drug 1294 1306	OTC inositol
T70	Eq-Comparison 1310 1318	previous
T71	Allergy 1319 1327	allergic
T72	Drug 1345 1355	supplement
T74	Drug 1366 1386	placebo maltodextrin
T76	Drug 1390 1396	inulin
T77	Life-Stage-And-Gender 25 30	Women
T78	Condition-Name 44 55	anovulation
T79	Condition-Name 59 73	oligomenorrhea
T80	Condition-Name 85 119	spontaneous intermenstrual periods
T81	Eq-Operator 123 144	greater than or equal
T82	Eq-Value 148 150	45
T83	Eq-Temporal-Unit 151 155	days
T84	Eq-Operator 170 179	less than
T85	Eq-Operator 180 188	or equal
T86	Eq-Value 192 193	8
T87	Observation-Name 194 200	menses
T88	Eq-Temporal-Unit 205 209	year
T89	Life-Stage-And-Gender 216 221	Women
T90	Condition-Name 227 243	Hyperandrogenism
T91	Observation-Name 257 275	total testosterone
T92	Eq-Operator 276 288	greater than
T93	Eq-Value 289 291	50
T94	Eq-Unit 292 294	ng
T95	Eq-Unit 295 297	dL
T96	Observation-Name 303 322	free androgen index
T97	Eq-Operator 323 335	greater than
T98	Eq-Value 336 338	10
T99	Life-Stage-And-Gender 345 350	Women
T100	Condition-Name 356 374	Polycystic Ovaries
T101	Procedure-Name 378 388	Ultrasound
T102	Eq-Value 407 409	12
T103	Eq-Operator 410 417	or more
T104	Observation-Name 418 437	follicles measuring
T105	Eq-Value 438 439	2
T106	Eq-Operator 439 440	-
T107	Eq-Value 440 441	9
T108	Eq-Unit 442 444	mm
T109	Polarity 460 469	increased
T110	Observation-Name 470 484	ovarian volume
T111	Eq-Operator 485 497	greater than
T112	Eq-Value 498 500	10
T113	Eq-Unit 501 503	cm
T114	Life-Stage-And-Gender 530 535	Women
T115	Condition-Name 541 559	Hyperprolactinemia
T116	Observation-Name 573 589	prolactin levels
T117	Eq-Operator 590 598	at least
T118	Eq-Value 599 602	one
T119	Eq-Temporal-Unit 603 607	week
T120	Eq-Operator 614 626	greater than
T121	Eq-Value 627 629	30
T122	Eq-Unit 630 632	ng
T123	Eq-Unit 633 635	mL
T124	Life-Stage-And-Gender 642 647	Women
T125	Condition-Name 659 684	21-hydroxylase deficiency
T126	Condition-Name 694 711	enzyme deficiency
T127	Condition-Name 727 757	congenital adrenal hyperplasia
T128	Life-Stage-And-Gender 764 769	Women
T129	Polarity 775 783	elevated
T130	Observation-Name 784 794	FSH levels
T131	Eq-Operator 795 807	greater than
T132	Eq-Value 808 810	10
T133	Eq-Unit 811 814	mIU
T134	Eq-Unit 815 818	mL.
T135	Life-Stage-And-Gender 824 829	Women
T136	Condition-Name 847 862	thyroid disease
T138	Observation-Name 912 915	TSH
T139	Eq-Operator 916 925	less than
T140	Eq-Value 926 930	0.45
T141	Eq-Unit 931 934	mIU
T142	Eq-Unit 935 937	mL
T143	Eq-Operator 941 953	greater than
T144	Eq-Value 954 957	4.5
T145	Eq-Unit 958 961	MIU
T146	Eq-Unit 962 964	mL
T147	Life-Stage-And-Gender 972 977	Women
T148	Condition-Name 1014 1019	tumor
T150	Life-Stage-And-Gender 1045 1050	Women
T151	Condition-Name 1056 1074	Cushing's syndrome
T152	Life-Stage-And-Gender 1080 1085	Women
T153	Stability 1119 1125	affect
T154	Condition-Name 1126 1142	ovarian function
T155	Drug-Name 1153 1162	metformin
T156	Drug-Name 1164 1187	hormonal contraceptives
T157	Condition-Name 1220 1228	diabetes
T158	Life-Stage-And-Gender 1234 1239	Women
T159	Drug-Name 1294 1306	OTC inositol
T160	Eq-Temporal-Period 1310 1318	previous
T161	Drug-Name 1366 1386	placebo maltodextrin
T162	Drug-Name 1390 1396	inulin
T163	Observation 194 200	menses
T164	Eq-Comparison 571 572	2
T165	Eq-Value 571 572	2
T166	Eq-Comparison 614 635	greater than 30 ng/mL
T36	Modifier 835 846	uncorrected
T53	Modifier 1020 1039	secreting androgens
T137	Eq-Temporal-Period 1086 1088	on
T149	Assertion 1119 1125	affect
T167	Modifier 1213 1219	type 2
A1	Assertion-Type-Value E48 possible
A2	Life-Stage-And-Gender-Type T77 female
A3	Eq-Operator-Value T81 GTEQ
A4	Eq-Temporal-Unit-Value T83 day
A5	Eq-Operator-Value T84 LT
A6	Eq-Operator-Value T85 GTEQ
A8	Eq-Temporal-Unit-Value T88 year
A9	Life-Stage-And-Gender-Type T89 female
A10	Observation-Type-Value E12 lab
A11	Eq-Operator-Value T92 GT
A12	Observation-Type-Value E15 lab
A13	Eq-Operator-Value T97 GT
A14	Life-Stage-And-Gender-Type T99 female
A15	Eq-Operator-Value T103 GTEQ
A16	Observation-Type-Value E21 measurement
A17	Eq-Operator-Value T106 BETWEEN
A18	Polarity-Value T109 high
A19	Observation-Type-Value E25 measurement
A20	Eq-Operator-Value T111 GT
A21	Life-Stage-And-Gender-Type T114 female
A22	Observation-Type-Value E29 lab
A23	Eq-Operator-Value T117 GTEQ
A24	Eq-Temporal-Unit-Value T119 week
A25	Eq-Operator-Value T120 GT
A26	Life-Stage-And-Gender-Type T124 female
A27	Life-Stage-And-Gender-Type T128 female
A28	Polarity-Value T129 high
A29	Observation-Type-Value E39 lab
A30	Eq-Operator-Value T131 GT
A31	Life-Stage-And-Gender-Type T135 female
A32	Observation-Type-Value E43 lab
A33	Eq-Operator-Value T139 LT
A34	Eq-Operator-Value T143 GT
A35	Life-Stage-And-Gender-Type T147 female
A36	Life-Stage-And-Gender-Type T150 female
A37	Life-Stage-And-Gender-Type T152 female
A38	Stability-Value T153 change
A39	Life-Stage-And-Gender-Type T158 female
A40	Eq-Temporal-Period-Value T160 past
A7	Eq-Temporal-Period-Value T137 present
A41	Assertion-Type-Value E80 hypothetical
A42	Acuteness-Type-Value T2 chronic
R1	Equivalent-To Arg1:E6 Arg2:E5
R2	Equivalent-To Arg1:E12 Arg2:E11
R3	Found-By Arg1:E18 Arg2:E19
R4	Equivalent-To Arg1:E29 Arg2:E28
R5	Caused-By Arg1:E37 Arg2:E35
R6	Caused-By Arg1:E37 Arg2:E32
R7	Equivalent-To Arg1:E43 Arg2:E42
R8	Caused-By Arg1:T153 Arg2:E57
R9	Example-Of Arg1:E59 Arg2:E57
R10	Example-Of Arg1:E60 Arg2:E57
R11	Treatment-For Arg1:E63 Arg2:E64
R12	Example-Of Arg1:E63 Arg2:E57
R13	Caused-By Arg1:E67 Arg2:E66
R14	And Arg1:T77 Arg2:T2
R15	Or Arg1:E3 Arg2:E5
R16	Or Arg1:E6 Arg2:E77
R17	And Arg1:T89 Arg2:E11
R18	Or Arg1:E12 Arg2:E15
R19	And Arg1:T99 Arg2:E18
R20	Or Arg1:E21 Arg2:E25
R21	And Arg1:T114 Arg2:E28
R22	And Arg1:T124 Arg2:E32
R23	Or Arg1:E32 Arg2:E35
R24	And Arg1:T128 Arg2:T129
R25	And Arg1:T135 Arg2:E42
R26	Or Arg1:E44 Arg2:E46
R27	And Arg1:T147 Arg2:E52
R28	Or Arg1:E49 Arg2:E51
R29	And Arg1:T150 Arg2:E55
R30	Or Arg1:E60 Arg2:E63
R31	And Arg1:T158 Arg2:E66
R32	Or Arg1:E67 Arg2:E71
R33	Or Arg1:E72 Arg2:E74
R34	Or Arg1:E74 Arg2:E76
R35	Or Arg1:E59 Arg2:E60
